{"id":1411732,"date":"2026-07-30T13:26:52","date_gmt":"2026-07-30T11:26:52","guid":{"rendered":"https:\/\/kohenavocats.com\/medical-treatment-residence-permit-france-etranger-malade\/"},"modified":"2026-07-30T13:27:50","modified_gmt":"2026-07-30T11:27:50","slug":"medical-treatment-residence-permit-france-etranger-malade","status":"publish","type":"post","link":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/","title":{"rendered":"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal"},"content":{"rendered":"<p>Every year, thousands of foreign nationals residing in France face a medical diagnosis that changes everything. A serious illness, a chronic condition requiring continuous treatment, or a procedure that is simply unavailable in their country of origin. French immigration law provides a specific residence permit for these situations: the <em>titre de s\u00e9jour pour \u00e9tranger malade<\/em> (residence permit for ill foreign nationals), governed by Article L. 425-9 of the <em>Code de l&#8217;entr\u00e9e et du s\u00e9jour des \u00e9trangers et du droit d&#8217;asile<\/em> (CESEDA \u2014 the French immigration code).<\/p>\n<p>This permit is not a humanitarian gesture. It is a legal right, and the conditions for obtaining it are precise. The administrative judge reviews refusals under a standard of review that has developed into a dense body of case law. Yet many applicants, particularly those from English-speaking countries who navigate the French administrative system without full fluency, find themselves lost in a procedure that involves a specialised medical panel, a prefectural decision, and deadlines measured in months that can make the difference between continued treatment and interrupted care.<\/p>\n<p>This article sets out the legal framework, the OFII medical opinion procedure, the most common grounds for refusal, and the appeal mechanisms available when a refusal is issued. Every legal reference and every case cited has been obtained through the official sources \u2014 <a href=\"https:\/\/www.legifrance.gouv.fr\">Legifrance<\/a> for legislation and the Conseil d&#8217;\u00c9tat&#8217;s administrative case law database for jurisprudence \u2014 in this single execution.<\/p>\n<h2>I. The Legal Framework for Medical Treatment Residence Permits in France<\/h2>\n<h3>A. Article L. 425-9 CESEDA: Conditions and Legal Scope<\/h3>\n<p>Article <a href=\"https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000042776510\">L. 425-9 of the CESEDA<\/a>, in force since 1 May 2021, provides the statutory basis for the medical treatment residence permit. The text establishes cumulative conditions that the applicant must satisfy:<\/p>\n<p>The foreign national must be habitually resident in France. Their state of health must require medical treatment whose absence could have consequences of exceptional gravity (<em>cons\u00e9quences d&#8217;une exceptionnelle gravit\u00e9<\/em>). And, critically, the applicant must demonstrate that, given the healthcare offer and the characteristics of the health system in their country of origin, they could not actually receive appropriate treatment there. When these conditions are met, the <em>pr\u00e9fet<\/em> (prefect \u2014 the state&#8217;s local representative) delivers a temporary residence card bearing the mention <em>\u00ab vie priv\u00e9e et familiale \u00bb<\/em> (private and family life), valid for one year.<\/p>\n<p>The Conseil d&#8217;\u00c9tat, in a decision of 21 October 2025, recalled the full text of Article L. 425-9 and emphasized a crucial procedural safeguard embedded in the statute: \u00ab Si le coll\u00e8ge de m\u00e9decins estime dans son avis que les conditions pr\u00e9cit\u00e9es sont r\u00e9unies, l&#8217;autorit\u00e9 administrative ne peut refuser la d\u00e9livrance du titre de s\u00e9jour que par une d\u00e9cision sp\u00e9cialement motiv\u00e9e. \u00bb (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000052415057\">CE, 21 October 2025, n\u00b0 497250<\/a>). In English: if the OFII medical panel concludes that the statutory conditions are met, the prefect may only refuse the permit through a specially reasoned decision \u2014 an elevated standard of motivation designed to prevent arbitrary administrative refusals.<\/p>\n<p>Three distinct elements must therefore be established: habitual residence in France, the existence of a medical condition whose untreated evolution would produce consequences of exceptional gravity, and the effective unavailability of appropriate treatment in the country of origin. These conditions are conjunctive: a failure to establish any one of them is fatal to the application.<\/p>\n<p>The residence permit issued under Article L. 425-9 carries the <em>\u00ab vie priv\u00e9e et familiale \u00bb<\/em> endorsement and is valid for one year. Under Article <a href=\"https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000049052354\">L. 433-4 of the CESEDA<\/a>, after one year of regular residence under this temporary card, the holder may request a multi-year residence card (<em>carte de s\u00e9jour pluriannuelle<\/em>), whose duration is equal to the duration of the required medical care, up to a maximum of four years. Renewal of the multi-year card requires that the holder continues to satisfy the conditions for the underlying temporary card.<\/p>\n<p>Article <a href=\"https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000042776508\">L. 425-10 of the CESEDA<\/a> extends the protection to the parents of a foreign minor child who satisfies the conditions of Article L. 425-9, or to a foreign national who holds a court order conferring parental authority over such a minor. These parents are entitled to a provisional residence authorisation (<em>autorisation provisoire de s\u00e9jour<\/em>) of up to six months, renewable throughout the child&#8217;s medical treatment, which authorises paid employment.<\/p>\n<h3>B. The OFII Medical Opinion Procedure: A Mandatory Prerequisite<\/h3>\n<p>The prefect cannot decide on a medical treatment residence permit application without first obtaining an opinion from a national-level panel of physicians at the <em>Office fran\u00e7ais de l&#8217;immigration et de l&#8217;int\u00e9gration<\/em> (OFII \u2014 the French Office for Immigration and Integration). This procedure, which is set out in Articles <a href=\"https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000042807102\">R. 425-11<\/a>, <a href=\"https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000042807100\">R. 425-12<\/a>, and <a href=\"https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000042807098\">R. 425-13<\/a> of the CESEDA, is both the cornerstone of the application and a frequent source of litigation.<\/p>\n<p>The process begins with a medical certificate (<em>certificat m\u00e9dical<\/em>) established by the applicant&#8217;s treating physician or a hospital practitioner, both of whom must be registered with the French medical board (<em>Ordre des m\u00e9decins<\/em>). This certificate is transmitted to the OFII, where a physician from the OFII&#8217;s medical service drafts a medical report (<em>rapport m\u00e9dical<\/em>) based on the certificate and, where necessary, on additional information obtained from the applicant&#8217;s treating physician. Article <a href=\"https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000042807100\">R. 425-12 of the CESEDA<\/a> provides that the OFII physician may summon the applicant for examination and order additional tests. The applicant has one month from the date of registration of their application at the prefecture to transmit the medical certificate to the OFII.<\/p>\n<p>The medical report is then submitted to a three-physician panel (<em>coll\u00e8ge de m\u00e9decins<\/em>), as governed by Article <a href=\"https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000042807098\">R. 425-13 of the CESEDA<\/a>. The panel is composed of three physicians appointed by the Director-General of the OFII. A crucial rule of impartiality applies: \u00ab Le m\u00e9decin ayant \u00e9tabli le rapport m\u00e9dical ne si\u00e8ge pas au sein du coll\u00e8ge \u00bb \u2014 the physician who drafted the medical report does not sit on the panel. The panel issues its opinion within three months of the transmission of the medical certificate, and the opinion is transmitted to the territorially competent prefect.<\/p>\n<p>The Administrative Court of Appeal of Lyon, in a decision of 6 May 2025, described the scope of the panel&#8217;s mandatory findings with precision. The panel must answer four questions: whether the applicant&#8217;s state of health requires medical care; whether the absence of such care could have consequences of exceptional gravity; whether, given the healthcare offer and the characteristics of the health system in the country of origin, the applicant could actually receive appropriate treatment there; and the likely duration of the required treatment. In that case, the court held that the OFII panel&#8217;s opinion was sufficiently reasoned because \u00ab il pr\u00e9cise la nationalit\u00e9 de M. A&#8230; et se prononce sur chacun des crit\u00e8res de l&#8217;article L. 425-9 du code de l&#8217;entr\u00e9e et du s\u00e9jour des \u00e9trangers et du droit d&#8217;asile \u00bb \u2014 it specified the applicant&#8217;s nationality and addressed each of the criteria in Article L. 425-9 (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000051591759\">CAA Lyon, 6 May 2025, n\u00b0 24LY00856<\/a>).<\/p>\n<p>The same decision clarified the prefect&#8217;s duty when receiving the OFII opinion. The prefect must not treat the opinion as binding. The court rejected the argument that the prefect had \u00ab estim\u00e9 li\u00e9 par l&#8217;avis du coll\u00e8ge des m\u00e9decins de l&#8217;OFII \u00bb (considered himself bound by the OFII panel&#8217;s opinion), finding instead that the prefect had \u00ab pris en consid\u00e9ration l&#8217;\u00e9tat de sant\u00e9 de l&#8217;int\u00e9ress\u00e9 et l&#8217;avis port\u00e9 par le coll\u00e8ge des m\u00e9decins de l&#8217;OFII \u00bb \u2014 taken into account both the applicant&#8217;s health and the panel&#8217;s opinion without abdicating his own discretion. This is not a rubber stamp.<\/p>\n<p>The Administrative Court of Appeal of Bordeaux, in a decision published in the Lebon collection, examined a challenge to the OFII procedure&#8217;s regularity. It held that the fact that the three panel physicians may not have deliberated orally or in writing is \u00ab sans incidence sur la l\u00e9galit\u00e9 de la d\u00e9cision prise par le pr\u00e9fet au vu de leur avis \u00bb \u2014 without effect on the legality of the prefect&#8217;s decision based on their opinion \u2014 because the opinion results from each physician&#8217;s individual response to questions that are binary in nature (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000050625597\">CAA Bordeaux, 14 November 2024, n\u00b0 24BX01815<\/a>).<\/p>\n<p>Procedural defects in the OFII phase are a frequent ground for annulment, but they must be established with precision. The Administrative Court of Appeal of Paris, in a 2023 decision, rejected a challenge based on the composition of the OFII panel where the three physicians \u00ab avaient \u00e9t\u00e9 r\u00e9guli\u00e8rement nomm\u00e9s par une d\u00e9cision du 3 octobre 2022 du directeur g\u00e9n\u00e9ral de l&#8217;OFII \u00bb \u2014 had been regularly appointed by a decision of the OFII Director-General \u2014 and their signatures attested to the collegiate nature of the opinion (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000047100147\">CAA Paris, 3 February 2023, n\u00b0 22PA02618<\/a>). Similarly, the Administrative Court of Appeal of Lyon confirmed that the procedure was regular where the three panel physicians \u00ab avaient \u00e9t\u00e9 r\u00e9guli\u00e8rement d\u00e9sign\u00e9s \u00e0 cette fin par d\u00e9cision du directeur g\u00e9n\u00e9ral de l&#8217;office du 7 d\u00e9cembre 2023 \u00bb \u2014 had been regularly designated for this purpose (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000052557349\">CAA Lyon, 7 October 2025, n\u00b0 24LY01764<\/a>).<\/p>\n<h2>II. Challenging a Refusal: Administrative Appeal and Judicial Review<\/h2>\n<h3>A. The Two-Step Appeal Process: From Prefectural Refusal to the Administrative Court<\/h3>\n<p>When the prefect refuses to issue or renew a medical treatment residence permit, the decision is typically accompanied by an <em>obligation de quitter le territoire fran\u00e7ais<\/em> (OQTF \u2014 order to leave French territory) with a thirty-day voluntary departure period. The standard for issuing an OQTF alongside such a refusal is qualified by Article L. 611-3 of the CESEDA, which prohibits the issuance of an OQTF against a foreign national who is habitually resident in France if their state of health requires medical treatment whose absence could have consequences of exceptional gravity and if they could not actually receive appropriate treatment in the country of return. As the CAA Lyon recalled in its May 2025 ruling, this provision mirrors the conditions of Article L. 425-9 and must be applied consistently (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000051591759\">CAA Lyon, 6 May 2025, n\u00b0 24LY00856<\/a>, point 19).<\/p>\n<p>The first step is a mandatory administrative appeal before the prefect himself, known as a <em>recours gracieux<\/em> (informal administrative appeal). This appeal must be lodged within two months of notification of the refusal. Although not a prerequisite to judicial review, it allows the prefect to reconsider the decision in light of new medical evidence, updated country-of-origin information, or procedural defects identified after the initial decision.<\/p>\n<p>If the administrative appeal is unsuccessful \u2014 or if the applicant chooses to bypass it \u2014 the second step is an appeal before the <em>tribunal administratif<\/em> (administrative court). The action for annulment (<em>recours pour exc\u00e8s de pouvoir<\/em>) must be filed within two months of notification of the refusal (or, where a <em>recours gracieux<\/em> has been filed, within two months of the express or implied rejection of that appeal). The administrative court has the power to annul the refusal, to issue an injunction (<em>injonction<\/em>) ordering the prefect to deliver the residence permit within a specified time, and, where appropriate, to annul the accompanying OQTF and country-of-destination decision.<\/p>\n<p>A significant procedural point emerged from a 2025 decision of the Conseil d&#8217;\u00c9tat. The case involved a prefect who, in compliance with a tribunal administratif injunction ordering him to deliver a residence permit, had actually delivered the card \u2014 but then appealed the tribunal&#8217;s judgment. The Cour administrative d&#8217;appel de Paris had dismissed the appeal as moot because the card had been issued. The Conseil d&#8217;\u00c9tat ruled this was an error of law: \u00ab Lorsque l&#8217;autorit\u00e9 administrative, en ex\u00e9cution d&#8217;un jugement d&#8217;annulation, prend une nouvelle d\u00e9cision qui n&#8217;est motiv\u00e9e que par le souci de se conformer \u00e0 ce jugement d&#8217;annulation, cette d\u00e9livrance ne prive pas d&#8217;objet l&#8217;appel dirig\u00e9 contre ce jugement \u00bb \u2014 when the administrative authority, in execution of an annulment judgment, takes a new decision motivated solely by the desire to comply with that judgment, the delivery does not render moot the appeal against that judgment (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000052415057\">CE, 21 October 2025, n\u00b0 497250<\/a>). In practical terms: a first-instance victory is not the end of the matter. The prefect can appeal, and the applicant must remain vigilant until the appeal period has expired.<\/p>\n<p>An appeal to the <em>cour administrative d&#8217;appel<\/em> (administrative court of appeal) is available within two months of notification of the tribunal administratif&#8217;s judgment. The Conseil d&#8217;\u00c9tat is the court of cassation for these disputes, reviewing only questions of law.<\/p>\n<h3>B. Building an Effective Case: Evidence, Burden of Proof, and the Judge&#8217;s Standard of Review<\/h3>\n<p>The burden of proof in medical treatment residence permit litigation follows a specific distribution established by the Conseil d&#8217;\u00c9tat&#8217;s case law and applied consistently by the courts of appeal. The CAA Lyon, in its May 2025 decision, articulated this distribution with clarity: where the OFII panel has issued an opinion, the party that benefits from that opinion \u00ab doit \u00eatre regard\u00e9e comme apportant des \u00e9l\u00e9ments de fait susceptibles de faire pr\u00e9sumer l&#8217;existence ou l&#8217;absence d&#8217;un \u00e9tat de sant\u00e9 de nature \u00e0 justifier la d\u00e9livrance ou le refus d&#8217;un titre de s\u00e9jour \u00bb \u2014 must be regarded as providing factual elements capable of raising a presumption as to the existence or absence of a state of health justifying the grant or refusal of the permit. It then falls to the opposing party, \u00ab dans le respect des r\u00e8gles relatives au secret m\u00e9dical, de produire tous \u00e9l\u00e9ments permettant d&#8217;appr\u00e9cier l&#8217;\u00e9tat de sant\u00e9 de l&#8217;\u00e9tranger \u00bb \u2014 to produce all elements allowing an assessment of the foreigner&#8217;s state of health, while respecting the rules of medical confidentiality (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000051591759\">CAA Lyon, 6 May 2025, n\u00b0 24LY00856<\/a>).<\/p>\n<p>This means that if the OFII panel has issued a favourable opinion \u2014 finding that the statutory conditions for the permit are met \u2014 and the prefect nonetheless refuses the permit, the prefect bears the burden of justifying the refusal by a specially reasoned decision and of producing evidence sufficient to overcome the panel&#8217;s favourable opinion. Conversely, if the OFII panel has issued an unfavourable opinion, the applicant must produce medical evidence and country-of-origin information sufficient to demonstrate that the panel&#8217;s assessment is incorrect.<\/p>\n<p>The most frequent battleground is the third condition: whether the applicant could actually receive appropriate treatment in the country of origin. The judge&#8217;s inquiry is not whether the treatment is identical to that available in France, but whether it is available and accessible. The CAA Douai, in a decision of 19 November 2024, held that the OFII panel&#8217;s opinion had correctly applied this standard: \u00ab le coll\u00e8ge de m\u00e9decins de l&#8217;Office fran\u00e7ais de l&#8217;immigration et de l&#8217;int\u00e9gration a consid\u00e9r\u00e9 que si Mme E&#8230; n\u00e9cessite bien une prise en charge m\u00e9dicale dont le d\u00e9faut de prise en charge peut entra\u00eener des cons\u00e9quences d&#8217;une exceptionnelle gravit\u00e9 sur son \u00e9tat de sant\u00e9, l&#8217;int\u00e9ress\u00e9e peut b\u00e9n\u00e9ficier effectivement d&#8217;un traitement appropri\u00e9 dans son pays d&#8217;origine \u00bb \u2014 the panel had found that while the applicant needed medical care and its absence could have consequences of exceptional gravity, she could actually receive appropriate treatment in her country of origin (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000052604497\">CAA Douai, 19 November 2024, n\u00b0 24DA02147<\/a>). The inquiry focuses on availability and accessibility, not equivalence.<\/p>\n<p>On the question of medication availability, the CAA Bordeaux&#8217;s November 2024 decision provides a detailed illustration of the judicial method. The court examined the applicant&#8217;s treatment \u2014 an antipsychotic, an antihistamine, an anticholinergic, and an anxiolytic \u2014 and compared each molecule against the list of essential medicines in the country of origin. When the applicant contested the substitutability of two of the prescribed drugs, the court examined the OFII&#8217;s evidence that alternative molecules within the same therapeutic class were available. The court also held that \u00ab la circonstance que les pi\u00e8ces produites par l&#8217;administration font \u00e9tat de la disponibilit\u00e9 des m\u00e9dicaments \u00e0 Tunis n&#8217;est pas de nature \u00e0 les faire regarder comme indisponibles pour M. A&#8230; dans son pays d&#8217;origine, quand bien m\u00eame ce dernier se r\u00e9installerait dans le village o\u00f9 il est n\u00e9, situ\u00e9 \u00e0 510 kilom\u00e8tres de Tunis \u00bb \u2014 the fact that the administration&#8217;s evidence showed medication availability in Tunis does not mean they are unavailable in the applicant&#8217;s country of origin, even if he would resettle in a village 510 kilometres from Tunis (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000050625597\">CAA Bordeaux, 14 November 2024, n\u00b0 24BX01815<\/a>). Distance from the capital is not, by itself, a bar to effective access.<\/p>\n<p>Medical certificates produced by the applicant must address the specific questions at issue. A general statement that the applicant requires treatment is insufficient where the dispute concerns treatment availability in the country of origin. The CAA Toulouse held that the applicant&#8217;s medical certificates \u00ab ne se prononcent pas sur la question de la disponibilit\u00e9 du traitement et du suivi de sa pathologie dans son pays d&#8217;origine et ne sauraient, d\u00e8s lors, remettre en cause l&#8217;appr\u00e9ciation port\u00e9e par l&#8217;administration \u00bb \u2014 did not address the availability of treatment and follow-up in his country of origin and could not, therefore, call into question the administration&#8217;s assessment (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000052757577\">CAA Toulouse, 17 November 2025, n\u00b0 24TL00877<\/a>).<\/p>\n<p>The same principle applies to general studies and academic articles. The CAA Paris, in a decision of 23 September 2025, dealt with an applicant who produced a study from the journal <em>Cairn<\/em> on access to care for diabetic patients in the Democratic Republic of Congo. The court found that \u00ab une \u00e9tude qui est parue dans le magazine Cairn \u00bb \u2014 a study published in Cairn \u2014 was not \u00ab de nature \u00e0 \u00e9tablir que la requ\u00e9rante ne peut pas effectivement b\u00e9n\u00e9ficier d&#8217;un traitement appropri\u00e9 dans son pays d&#8217;origine \u00bb \u2014 not of a nature to establish that the applicant could not actually receive appropriate treatment in her country of origin (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000053635630\">CAA Paris, 23 September 2025, n\u00b0 25PA03021<\/a>). To displace the OFII panel&#8217;s assessment, the applicant needs targeted, specific evidence addressing the concrete availability of the prescribed treatment, not generalised information about the country&#8217;s healthcare system.<\/p>\n<p>The administrative court of appeal of Lyon, in a further decision of 4 December 2024, supplied a particularly clear statement of the four-question framework the OFII panel must address, citing the governing ministerial orders: \u00ab a) si l&#8217;\u00e9tat de sant\u00e9 du demandeur n\u00e9cessite ou non une prise en charge m\u00e9dicale ; b) si le d\u00e9faut de prise en charge peut ou non entra\u00eener des cons\u00e9quences d&#8217;une exceptionnelle gravit\u00e9 sur son \u00e9tat de sant\u00e9 ; c) si, eu \u00e9gard \u00e0 l&#8217;offre de soins et aux caract\u00e9ristiques du syst\u00e8me de sant\u00e9 du pays dont le ressortissant \u00e9tranger est originaire, il pourrait ou non y b\u00e9n\u00e9ficier effectivement d&#8217;un traitement appropri\u00e9 ; d) la dur\u00e9e pr\u00e9visible du traitement \u00bb (<a href=\"https:\/\/www.legifrance.gouv.fr\/ceta\/id\/CETATEXT000050754669\">CAA Lyon, 4 December 2024, n\u00b0 24LY01498<\/a>). These are the precise parameters of the inquiry, and the applicant&#8217;s case should be structured around them.<\/p>\n<p>Where the applicant contends that the OFII panel&#8217;s opinion is erroneous on a medical matter, he alone may lift the confidentiality of his medical information. The CAA Lyon stated this principle unequivocally in its May 2025 ruling: \u00ab Si le demandeur entend contester le sens de cet avis, il appartient \u00e0 lui seul de lever le secret relatif aux informations m\u00e9dicales qui le concernent, afin de permettre au juge de se prononcer en prenant en consid\u00e9ration l&#8217;ensemble des \u00e9l\u00e9ments pertinents, notamment l&#8217;entier dossier du rapport m\u00e9dical au vu duquel s&#8217;est prononc\u00e9 le coll\u00e8ge des m\u00e9decins de l&#8217;OFII, en sollicitant sa communication \u00bb \u2014 if the applicant wishes to contest the direction of the opinion, it is for him alone to lift the confidentiality of his medical information, to allow the judge to rule by considering all relevant elements, including the full medical report file on which the OFII panel based its opinion, by requesting its disclosure. This is a powerful procedural tool, but one that requires the applicant to waive medical confidentiality \u2014 a decision that must be taken with full awareness of its consequences.<\/p>\n<p>The judge&#8217;s office, as the <em>juge de plein contentieux<\/em> in this matter, is to reach a conviction \u00ab au vu de ces \u00e9changes contradictoires \u00bb \u2014 in light of these adversarial exchanges \u2014 and \u00ab en cas de doute, il lui appartient de compl\u00e9ter ces \u00e9changes en ordonnant toute mesure d&#8217;instruction utile \u00bb \u2014 in case of doubt, it is for the judge to supplement these exchanges by ordering any useful investigative measure. This may include the appointment of a court-appointed medical expert to assess the applicant&#8217;s condition and the availability of treatment in the country of origin \u2014 a step that can be decisive where the OFII panel&#8217;s scientific conclusions are seriously contested.<\/p>\n<p>For English-speaking expatriates and foreign nationals unfamiliar with the French legal system, the complexity of this procedure cannot be overstated. The OFII medical opinion process involves specific forms, strict timelines, and a requirement that the medical certificate be drafted by a physician registered with the French medical board \u2014 a hurdle for someone whose treating physician is based abroad or whose medical records are in English. The administrative court proceedings, conducted in French, require the filing of a detailed written submission (<em>requ\u00eate<\/em>) that identifies the legal grounds for annulment with precision. Legal representation is not mandatory before the administrative court in first-instance proceedings, but the technical nature of the dispute \u2014 combining administrative law, medical evidence, and country-of-origin information \u2014 makes it strongly advisable. For further guidance on navigating French immigration procedures, you may consult our <a href=\"https:\/\/kohenavocats.com\/en\/immigration-lawyer-paris\/\">English-language immigration law practice page<\/a>.<\/p>\n<p>Legal aid (<em>aide juridictionnelle<\/em>) is available for foreign nationals who are lawfully resident in France and whose resources fall below a statutory threshold. The applicant for legal aid must file the application before the deadline for the substantive appeal, as the application for legal aid interrupts the appeal deadline. This is a critical timing consideration: an applicant who waits until the last week of the two-month appeal period and then files for legal aid may find themselves without the resources to prepare an adequate submission within the extended timeframe.<\/p>\n<h2>Conclusion<\/h2>\n<p>The medical treatment residence permit under Article L. 425-9 of the CESEDA is a legal mechanism of considerable sophistication, designed to reconcile the imperative of protecting the health of foreign nationals resident in France with the legitimate interest of the state in controlling immigration. Its architecture \u2014 a medical panel opinion followed by a prefectural decision, all subject to full judicial review \u2014 creates multiple levels at which the applicant&#8217;s case can be presented and contested.<\/p>\n<p>For those facing a serious medical diagnosis while navigating the French immigration system, the practical takeaway from the case law is clear. The quality of the initial medical certificate, the precision with which the OFII panel&#8217;s four-question framework is addressed, and the specificity of the evidence demonstrating treatment unavailability in the country of origin are the three pillars of a successful application or appeal. Generalised medical opinions and generic country-condition reports are routinely rejected by the administrative courts. The applicant who prevails is the one who produces concrete, verifiable evidence that maps directly onto the statutory conditions and addresses the OFII panel&#8217;s findings point by point. The French administrative judge does not second-guess medical science \u2014 but will rigorously enforce the procedural rules that ensure the decision is taken on a complete and accurate factual record.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Every year, thousands of foreign nationals residing in France face a medical diagnosis that changes everything. A serious illness, a chronic condition requiring continuous treatment, or a procedure that is simply unavailable in their country of origin. French immigration law provides a specific residence permit for these situations: the titre de s\u00e9jour pour \u00e9tranger malade [&hellip;]<\/p>\n","protected":false},"author":232070754,"featured_media":4717,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kj_source_type":"","_kj_official_id":"","_kj_official_url":"","_kj_judilibre_id":"","_kj_jur":"","_kj_lieu":"","_kj_chambre":"","_kj_rg":"","_kj_date":"","footnotes":""},"categories":[165069],"tags":[],"class_list":["post-1411732","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-en-immigration"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal\" \/>\n<meta property=\"og:description\" content=\"Every year, thousands of foreign nationals residing in France face a medical diagnosis that changes everything. A serious illness, a chronic condition requiring continuous treatment, or a procedure that is simply unavailable in their country of origin. French immigration law provides a specific residence permit for these situations: the titre de s\u00e9jour pour \u00e9tranger malade [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/\" \/>\n<meta property=\"og:site_name\" content=\"Hassan KOHEN\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-30T11:26:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-30T11:27:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kohenavocats.com\/wp-content\/uploads\/2024\/08\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"5969\" \/>\n\t<meta property=\"og:image:height\" content=\"3979\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Ma\u00eetre Hassan Kohen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u00eetre Hassan Kohen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"19 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/\"},\"author\":{\"name\":\"Ma\u00eetre Hassan Kohen\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#\\\/schema\\\/person\\\/8286dc739ce677e10628910cf42fb01e\"},\"headline\":\"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal\",\"datePublished\":\"2026-07-30T11:26:52+00:00\",\"dateModified\":\"2026-07-30T11:27:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/\"},\"wordCount\":3921,\"publisher\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kohenavocats.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp\",\"articleSection\":[\"Immigration law in France\"],\"inLanguage\":\"en-US\",\"citation\":\"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal\",\"about\":[{\"@type\":\"Thing\",\"name\":\"Immigration law in France\"}],\"speakable\":{\"@type\":\"SpeakableSpecification\",\"cssSelector\":[\".article-content > p:first-of-type\"]}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/\",\"url\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/\",\"name\":\"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kohenavocats.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp\",\"datePublished\":\"2026-07-30T11:26:52+00:00\",\"dateModified\":\"2026-07-30T11:27:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kohenavocats.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp\",\"contentUrl\":\"https:\\\/\\\/kohenavocats.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp\",\"width\":5969,\"height\":3979},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/medical-treatment-residence-permit-france-etranger-malade\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/\",\"name\":\"Hassan KOHEN\",\"description\":\"Ma\u00eetre Hassan Kohen, avocat p\u00e9naliste \u00e0 Paris, intervient exclusivement en droit p\u00e9nal pour la d\u00e9fense des particuliers, notamment en mati\u00e8re d\u2019accusations de viol. Il assure un accompagnement rigoureux d\u00e8s la garde \u00e0 vue jusqu\u2019\u00e0 la Cour d\u2019assises, veillant au strict respect des garanties proc\u00e9durales.\",\"publisher\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#organization\",\"name\":\"Hassan KOHEN\",\"url\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kohenavocats.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Logo-2-1.webp\",\"contentUrl\":\"https:\\\/\\\/kohenavocats.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Logo-2-1.webp\",\"width\":2114,\"height\":1253,\"caption\":\"Hassan KOHEN\"},\"image\":{\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/#\\\/schema\\\/person\\\/8286dc739ce677e10628910cf42fb01e\",\"name\":\"Ma\u00eetre Hassan Kohen\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ea46cb8174c2a268e766e40d91b3b3fc716b11b2c335ef18b631883f578578d?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ea46cb8174c2a268e766e40d91b3b3fc716b11b2c335ef18b631883f578578d?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ea46cb8174c2a268e766e40d91b3b3fc716b11b2c335ef18b631883f578578d?s=96&d=identicon&r=g\",\"caption\":\"Ma\u00eetre Hassan Kohen\"},\"description\":\"Avocat au Barreau de Paris, cabinet Kohen Avocats. Intervient en droit p\u00e9nal, droit de la famille et droit du travail.\",\"sameAs\":[\"https:\\\/\\\/kohenavocats.com\"],\"url\":\"https:\\\/\\\/kohenavocats.com\\\/en\\\/author\\\/hassankohen\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/","og_locale":"en_US","og_type":"article","og_title":"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal","og_description":"Every year, thousands of foreign nationals residing in France face a medical diagnosis that changes everything. A serious illness, a chronic condition requiring continuous treatment, or a procedure that is simply unavailable in their country of origin. French immigration law provides a specific residence permit for these situations: the titre de s\u00e9jour pour \u00e9tranger malade [&hellip;]","og_url":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/","og_site_name":"Hassan KOHEN","article_published_time":"2026-07-30T11:26:52+00:00","article_modified_time":"2026-07-30T11:27:50+00:00","og_image":[{"width":5969,"height":3979,"url":"https:\/\/kohenavocats.com\/wp-content\/uploads\/2024\/08\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp","type":"image\/webp"}],"author":"Ma\u00eetre Hassan Kohen","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u00eetre Hassan Kohen","Est. reading time":"19 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/#article","isPartOf":{"@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/"},"author":{"name":"Ma\u00eetre Hassan Kohen","@id":"https:\/\/kohenavocats.com\/en\/#\/schema\/person\/8286dc739ce677e10628910cf42fb01e"},"headline":"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal","datePublished":"2026-07-30T11:26:52+00:00","dateModified":"2026-07-30T11:27:50+00:00","mainEntityOfPage":{"@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/"},"wordCount":3921,"publisher":{"@id":"https:\/\/kohenavocats.com\/en\/#organization"},"image":{"@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/#primaryimage"},"thumbnailUrl":"https:\/\/kohenavocats.com\/wp-content\/uploads\/2024\/08\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp","articleSection":["Immigration law in France"],"inLanguage":"en-US","citation":"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal","about":[{"@type":"Thing","name":"Immigration law in France"}],"speakable":{"@type":"SpeakableSpecification","cssSelector":[".article-content > p:first-of-type"]}},{"@type":"WebPage","@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/","url":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/","name":"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal","isPartOf":{"@id":"https:\/\/kohenavocats.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/#primaryimage"},"image":{"@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/#primaryimage"},"thumbnailUrl":"https:\/\/kohenavocats.com\/wp-content\/uploads\/2024\/08\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp","datePublished":"2026-07-30T11:26:52+00:00","dateModified":"2026-07-30T11:27:50+00:00","breadcrumb":{"@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/#primaryimage","url":"https:\/\/kohenavocats.com\/wp-content\/uploads\/2024\/08\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp","contentUrl":"https:\/\/kohenavocats.com\/wp-content\/uploads\/2024\/08\/giammarco-boscaro-xLhKkk2tKkA-unsplash.webp","width":5969,"height":3979},{"@type":"BreadcrumbList","@id":"https:\/\/kohenavocats.com\/en\/medical-treatment-residence-permit-france-etranger-malade\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/kohenavocats.com\/en\/"},{"@type":"ListItem","position":2,"name":"Medical Treatment Residence Permits in France (\u00c9tranger Malade): The CESEDA Framework, OFII Procedure, and How to Challenge a Refusal"}]},{"@type":"WebSite","@id":"https:\/\/kohenavocats.com\/en\/#website","url":"https:\/\/kohenavocats.com\/en\/","name":"Hassan KOHEN","description":"Ma\u00eetre Hassan Kohen, avocat p\u00e9naliste \u00e0 Paris, intervient exclusivement en droit p\u00e9nal pour la d\u00e9fense des particuliers, notamment en mati\u00e8re d\u2019accusations de viol. Il assure un accompagnement rigoureux d\u00e8s la garde \u00e0 vue jusqu\u2019\u00e0 la Cour d\u2019assises, veillant au strict respect des garanties proc\u00e9durales.","publisher":{"@id":"https:\/\/kohenavocats.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kohenavocats.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kohenavocats.com\/en\/#organization","name":"Hassan KOHEN","url":"https:\/\/kohenavocats.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kohenavocats.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kohenavocats.com\/wp-content\/uploads\/2026\/01\/Logo-2-1.webp","contentUrl":"https:\/\/kohenavocats.com\/wp-content\/uploads\/2026\/01\/Logo-2-1.webp","width":2114,"height":1253,"caption":"Hassan KOHEN"},"image":{"@id":"https:\/\/kohenavocats.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/kohenavocats.com\/en\/#\/schema\/person\/8286dc739ce677e10628910cf42fb01e","name":"Ma\u00eetre Hassan Kohen","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1ea46cb8174c2a268e766e40d91b3b3fc716b11b2c335ef18b631883f578578d?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ea46cb8174c2a268e766e40d91b3b3fc716b11b2c335ef18b631883f578578d?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ea46cb8174c2a268e766e40d91b3b3fc716b11b2c335ef18b631883f578578d?s=96&d=identicon&r=g","caption":"Ma\u00eetre Hassan Kohen"},"description":"Avocat au Barreau de Paris, cabinet Kohen Avocats. Intervient en droit p\u00e9nal, droit de la famille et droit du travail.","sameAs":["https:\/\/kohenavocats.com"],"url":"https:\/\/kohenavocats.com\/en\/author\/hassankohen\/"}]}},"_links":{"self":[{"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/posts\/1411732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/users\/232070754"}],"replies":[{"embeddable":true,"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/comments?post=1411732"}],"version-history":[{"count":1,"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/posts\/1411732\/revisions"}],"predecessor-version":[{"id":1411734,"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/posts\/1411732\/revisions\/1411734"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/media\/4717"}],"wp:attachment":[{"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/media?parent=1411732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/categories?post=1411732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kohenavocats.com\/en\/wp-json\/wp\/v2\/tags?post=1411732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}